医学
荟萃分析
出版偏见
漏斗图
内科学
肿瘤科
危险系数
随机对照试验
子群分析
宫颈癌
佐剂
癌症
置信区间
作者
Nanda Horeweg,Prachi Mittal,Patrycja Gradowska,Ingrid Boere,Remi A. Nout,Supriya Chopra
标识
DOI:10.1016/j.critrevonc.2022.103638
摘要
We investigated whether the addition of adjuvant chemotherapy to chemoradiation improves overall survival (OS) and progression-free survival (PFS) by conducting a systematic review and meta-analysis. Systematic searches in the databases of PubMed, Embase and Web of Science yielded 881 articles. Two reviewer authors independently selected 31 articles for full text review and deemed eight studies eligible for inclusion. Two were randomised controlled trials (RCT), one was a large (n = 609) matched-case study and the remaining were small retrospective cohort studies; in total 2150 patients. Risk of bias assessment showed that the RCTs were at low risk and all other studies were at high risk of bias. Pooled hazard ratios for OS and PFS were 0.78 (95%CI 0.45-1.33, p = 0.36) and 0.85 (95%CI 0.65-1.10, p = 0.22), respectively. Analysis stratified by study design and sensitivity analysis showed similar results. Funnel plots showed significant publication bias due to a lack of small studies with negative outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI